BioCentury
BioCentury
YouTubeLinkedInXRSS
ARTICLE | Distillery Therapeutics

Dual-targeting CAR T cells with split costimulation and a shared CD3 chain

By Biocentury Staff
October 27, 2021 5:05 PM UTC

DISEASE CATEGORY: Cancer

INDICATION: Brain cancer, solid tumors...

BCIQ Company Profiles

University of North Carolina at Chapel Hill

BCIQ Target Profiles

B7-H3 (CD276)

CD28

Ganglioside GD2 (GD2)

Tumor necrosis factor (TNF) receptor superfamily member 9 (4-1BB) (TNFRSF9) (CD137)

BCIQ Company Profiles

University of North Carolina at Chapel Hill

BCIQ Target Profiles

B7-H3 (CD276)

CD28

Ganglioside GD2 (GD2)

Tumor necrosis factor (TNF) receptor superfamily member 9 (4-1BB) (TNFRSF9) (CD137)

About BioCentury

Privacy & Legal

Contact

About BioCentury

Company Overview
Management
Editorial & Research
Scientific Advisory Board

Privacy & Legal

User Agreement
Terms of Use
Privacy Policy
Use of Images & Market Data
Reprints & Permissions

Contact

Contact Us
Advertising & Sponsorship
Customer Resource Center
Career Opportunities
Forgot Password
YouTubeLinkedInXRSS
BioCentury
© 2025 BioCentury Inc. All Rights Reserved.
Copyright © 2025 BioCentury Inc. All Rights Reserved.
YouTubeLinkedInXRSS